| |
| |
|
| Insider
Information: |
Bowden Christopher |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
59,654 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$570,244 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
59,654 |
|
|
| Total
Value |
$570,244 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Agios Pharmaceuticals Inc |
AGIO |
Chief Medical Officer |
2021-06-18 |
15,487 |
2015-06-01 |
0 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director |
2022-06-22 |
44,167 |
2021-03-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
70 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2019-01-22 |
4 |
D |
$52.82 |
$103,527 |
D/D |
(1,960) |
5,229 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2019-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,750 |
8,013 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2019-02-19 |
4 |
D |
$58.03 |
$47,469 |
D/D |
(818) |
7,195 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2019-03-15 |
4 |
AS |
$64.09 |
$641,615 |
D/D |
(10,000) |
7,238 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2019-03-15 |
4 |
OE |
$35.16 |
$351,600 |
D/D |
10,000 |
17,238 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2019-04-01 |
4 |
AS |
$66.03 |
$665,747 |
D/D |
(10,000) |
7,238 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2019-04-01 |
4 |
OE |
$35.16 |
$351,600 |
D/D |
10,000 |
17,238 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2020-02-04 |
4 |
AS |
$50.03 |
$2,485,989 |
D/D |
(49,638) |
1,650 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2020-02-04 |
4 |
OE |
$35.16 |
$299,774 |
D/D |
8,526 |
15,841 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2020-02-05 |
4 |
OE |
$35.16 |
$1,246,317 |
D/D |
35,447 |
37,097 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2020-02-11 |
4 |
AS |
$50.02 |
$31,063 |
D/D |
(621) |
1,650 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2020-02-11 |
4 |
OE |
$35.16 |
$21,834 |
D/D |
621 |
2,271 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2020-02-13 |
4 |
AS |
$50.16 |
$356,112 |
D/D |
(7,100) |
1,650 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2020-02-13 |
4 |
OE |
$35.16 |
$249,636 |
D/D |
7,100 |
8,750 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2020-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,750 |
4,400 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2020-02-18 |
4 |
D |
$52.01 |
$42,596 |
D/D |
(819) |
3,581 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2020-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,333 |
6,914 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2020-02-24 |
4 |
D |
$48.66 |
$77,661 |
D/D |
(1,596) |
5,318 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2020-04-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,280 |
10,598 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2020-04-14 |
4 |
D |
$40.64 |
$96,236 |
D/D |
(2,368) |
8,230 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2020-05-20 |
4 |
AS |
$50.01 |
$179,200 |
D/D |
(3,583) |
8,306 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2020-05-20 |
4 |
OE |
$35.16 |
$125,978 |
D/D |
3,583 |
11,889 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,000 |
12,381 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-02-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,069) |
13,062 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,750 |
15,131 |
0 |
- |
|
70 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
